Back to Agenda
Session 7, Track A: CTD/eCTD and Cloud-based System Solutions: Future Vision
Session Chair(s)
Flavia Firmino Ribeiro, PharmD
Director Reg Global CMC
Pfizer, Brazil
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Representative Invited
AstraZeneca, United States
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Representative Invited
Merck Serono Limited, United Kingdom
In this session, speakers will discuss the future vision and potential enhancements of CTD and eCTD for regulatory submissions. The session will explore advancements in technology and best practices that can further improve the effectiveness and acceptance of these formats. Participants will also have the opportunity to recognize the importance of digital ways of work including eCTD implementation, without ignoring the different challenges and numerous advantages.
Learning Objective : - Recognize eCTD's foundational significance and assess its adaptability and inherent limitations amidst rapid technological advancements in the cloud era
- Identify how cloud platforms can address eCTD's limitations, fostering enhanced information
Speaker(s)
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
eCTD in a Cloud Era: Evolution, Integration, and the Future of Regulatory Submissions
Representative Invited
Merck Serono Limited, United Kingdom
Have an account?